Chutko L S, Surushkina S Yu, Yakovenko E A, Anisimova T I, Antokhin E Yu, Kryukova E Yu
N. Bekhtereva Institute of Human Brain Russian Academy of Sciences, St.-Petersburg, Russia.
Orenburg State Medical University, Orenburg, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12):31-35. doi: 10.17116/jnevro201811812131.
To study cognitive impairment in adults with attention deficit hyperactivity disorder (ADHD) and assess the efficacy of cerebrolysin in the treatment of such patients.
Thirty-eight patients with ADHD, aged from 18 to 45 years were enrolled in the study. Along with general neurological examination, several ADHA-specific scales and tests (ASRS-V1-1, SFQ, BIS, the Emotional Intelligence Self-Evaluation, TOVA) were administered.
There was a significant increase in inattention and impulsivity in comparison with the control group, which can be regarded as a decrease in cognitive control. The results of the study showed that cerebrolysin was an effective tool for improving cognitive control in adult patients with ADHD (a significant improvement was noted in 42.1% of patients, improvement in 31.6% of patients).
